Approximately $1.26 billion worth of counterfeit goods originating overseas were seized by the U.S. Customs and Border Protection (CBP) in 2012. Each seizure averaged $10,450 worth of counterfeit goods. The value and the number of seizures changes dramatically each year due to the products sold and the success of CBP operations. The value of handbags and wallets seized in 2012 rose 142% compared with the previous year.
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions based in York, UK, announced the addition of its ORCA™ 2.0 range of products. The announcement was made today at the IQPC Cool Chain Logistics conference.
The healthcare industry continues to grow, adding 45,000 jobs last December, but the medical device and pharmaceutical sectors are facing challenges - namely increasing taxes and fees - that industry representatives say are sure to slow growth. The recently implemented medical device tax, increased user fees, and pricing pressures are certainly weighing on the industry, but a new report from MedReps.com suggests the healthcare sales job market has not seen strong repercussions.
Manufacturers concerned about the proliferation of counterfeit drugs are working to implement serialized packaging to support full traceability, product integrity, supply-chain security and patient safety. Conventional serialization solutions multiplex cameras from an industrial PC to distribute vision at multiple points on the production line. Maintenance and validation can be expensive because of the need to deal with a complex operating system and custom software.
ULURU Inc. (OTCQB: ULUR) announced today the availability in the U.S. market of Altrazeal® in an innovative 0.75 gram blister pack.The development of this innovative packaging system was in response to requests from wound care practitioners. This packaging configuration overcomes the concerns expressed by users, including excessive waste of product, inability to see the product during application and unit cost for the treatment of small chronic wounds.
SPI: The Plastics Industry Trade Association is pleased to announce the publication of an update to its 2003 Guidelines for the Development of Type III Drug Master Files. This manual, prepared by the SPI Pharmaceutical and Medical Device Applications Committee, is a guide to the regulatory considerations and procedures to be taken into account when establishing a Type III Drug Master File. The new updates reflect procedural changes at the U.S. Food and Drug Administration and "best practices" amassed by the law firm of Keller and Heckman.
Mayor Greg Ballard today joined Roche Diagnostics President and CEO Jack Phillips as well as other Roche executives and community leaders to break ground on the company's new Learning and Development Center. The center is the first element of a $300 million site transformation investment that was announced in June 2012. The city of Indianapolis and the Indiana Economic Development Corporation offered Roche tax abatements, tax credits and training grants to support Roche's investment.
The Klöckner Pentaplast Group announced today that it will add to its global production capacity in Asia, the Americas, and Europe. The company is investing $51.8 million USD (€39.6 Mio) for this expansion which includes facilities in Suzhou, China; Cotia, Brazil; and Santo Tirso, Portugal. 137 employees will be added worldwide. Klöckner Pentaplast is the only rigid films producer with manufacturing sites located in the Americas, Asia, and Europe.
Coding and marking specialist Linx Printing Technologies has unveiled the latest evolution in continuous ink jet printers.
A new robot control developed by Optima Pharma specifically developed for handling pharmaceutical liquids provides new and flexible methods for pharmaceutical use. It underscores the highly developed competencies at Optima Pharma.